Condition

HR Positive/HER2 Low Breast Cancer clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Neoadjuvant trastuzumab rezetecan plus toripalimab for HR‑positive, HER2‑low breast cancer

  This trial will test whether giving trastuzumab rezetecan with toripalimab before surgery helps people with HR‑positive/HER2‑low breast cancer shrink tumors and achieve complete responses.

  Recruiting at 5 sites Phase 2 First Affiliated Hospital of Zhejiang University · Harbin and 4 other locations · NCT07383818

• Neoadjuvant treatment for HR Positive/HER2 Low Breast Cancer using SHR-A1811 and Adebrelimab

  This study is testing a new treatment combination for people with Stage II-III HR Positive/HER2 Low Breast Cancer to see if it can help shrink tumors before surgery.

  Recruiting Phase 2 Shengjing Hospital · Shenyang, Liaoning · NCT06340230

Related topics

Quick answers

How many HR Positive/HER2 Low Breast Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →